MyMSTeam

Which high-efficacy DMTs help with PIRA in MS?

High-efficacy DMTs appear to slow the progression of PIRA (progression independent of relapse activity) better than other MS treatments. These medications work to reduce silent progression that happens outside of relapses.

The high-efficacy DMTs that have shown effectiveness Show Full Answer

Which high-efficacy DMTs help with PIRA in MS?

High-efficacy DMTs appear to slow the progression of PIRA (progression independent of relapse activity) better than other MS treatments. These medications work to reduce silent progression that happens outside of relapses.

The high-efficacy DMTs that have shown effectiveness include:

* Alemtuzumab (Lemtrada)
* Natalizumab (Tysabri)
* Ocrelizumab (Ocrevus)
* Ofatumumab (Kesimpta)
* Ublituximab (Briumvi)
* Cladribine (Mavenclad)
* Fingolimod (Gilenya)
* Siponimod (Mayzent)
* Ozanimod (Zeposia)
* Rituximab (Rituxan)
* Mitoxantrone (Novantrone)

Research shows that starting high-efficacy therapies early in MS appears to have the biggest effect in reducing PIRA symptoms and preventing long-term disability. Many doctors now recommend these treatments earlier to slow silent progression.

However, high-efficacy DMTs can carry risks of serious side effects, so it's important to discuss the benefits and risks with your neurologist to find the right treatment for your situation.

 AI-generated responses are not a substitute for medical advice. These services are not intended to diagnose, treat, or cure any condition or disease. Always ask your doctor about specific health concerns.

Most Effective Treatments for MS: Benefits and Side Effects

Top 5 Medications Used by MyMSTeam Members